Clinical Trial

A Study of Anti-BCMA CAR-T Therapy in Newly Diagnosed Myeloma Patients Who Are Transplant-ineligible

Name: A Study of Anti-BCMA CAR-T Therapy in Newly Diagnosed Myeloma Patients Who Are Transplant-ineligible — clinical trial record (NCT07070960)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: CAR-T

Not Yet Recruiting

View on ClinicalTrials.gov →

Record status

This record was last updated July 17, 2025 (before its estimated July 15, 2026 completion). Its status may not reflect the trial's current state.

Summary

This is a prospective study of anti-BCMA CAR-T in transplant-ineligible patients with newly diagnosed multiple myeloma.

Trial Details

NCT Number	NCT07070960
Lead Sponsor	Xuzhou Medical University
Conditions	Multiple Myeloma, Newly Diagnosed
Enrollment	35 participants
Start Date	2025-07-15
Primary Completion	2026-07-15 (estimated)
Study Completion	2028-07-31 (estimated)
Updated on ClinicalTrials.gov	2025-07-17